Aquestive Therapeutics Inc (NAS:AQST)
$ 3.27 0.18 (5.83%) Market Cap: 297.69 Mil Enterprise Value: 220.59 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Q1 2019 Aquestive Therapeutics Inc Earnings Call Transcript

May 08, 2019 / 12:00PM GMT
Release Date Price: $4.52 (-17.06%)
Operator

Good morning, and welcome to the Aquestive Therapeutics First Quarter 2019 Conference Call. (Operator Instructions) As a reminder, this call will be recorded. I would now like to introduce your host for today's conference, Ms. Lauren Walrath, Head, Corporate Marketing and Communications. You may begin.

Lauren Walrath
Aquestive Therapeutics, Inc. - Head of Corporate Marketing & Communications

Thank you, operator. Good morning, and welcome to today's call to review Aquestive Therapeutics' results for the first quarter 2019. On today's call, I am joined by Keith Kendall, Chief Executive Officer; Ken Marshall, Chief Commercial Officer; Dan Barber, Chief Strategy and Development Officer; John Maxwell, Chief Financial Officer and Lori Braender, General Counsel.

Over the course of this call, we will provide an overview of business developments through Q1 of this year and discuss the progress we continue to make with respect to our 2019 goals and performance targets. Following these remarks, we will open the call to your questions. We expect today's call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot